Physician profile
Joan E Halley
NPI 1013994565
$875.53
in general payments reported to CMS, 2019-2025
23 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $187 · 2021: $43.98 · 2023: $20.82 · 2024: $83.94 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $139.53 | 2021-2025 | |
| Novo Nordisk INC | $104.98 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.94 | 2019 | |
| Lilly USA, LLC | $63.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $60.38 | 2019 | |
| Sanofi Pasteur INC. | $40.43 | 2020-2023 | |
| Pfizer INC. | $38.32 | 2019-2024 | |
| Glaxosmithkline, LLC. | $38.06 | 2019-2020 | |
| Allergan, INC. | $37.61 | 2019 | |
| Amgen INC. | $36.83 | 2019 | |
| Phathom Pharmaceuticals, INC. | $30.67 | 2024 | Voquezna |
| Nevro Corp. | $22.63 | 2020 | |
| Inspire Medical Systems, INC. | $21.69 | 2025 | Inspire |
| Hologic Sales and Service, LLC | $20.79 | 2025 | Thinprep 2000 Processor, Aptima |
| Genentech USA, INC. | $20.37 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $20.29 | 2020 | |
| Boston Scientific Corporation | $20.17 | 2020 | |
| Grifols USA, LLC | $19.93 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.63 | 2020 | |
| Merck Sharp & Dohme LLC | $12.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Halley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.